卡塔尔波尔通过TLR4/MAPK/NF-Kb通路抑制NLRP3炎症酶来缓解抑郁症
Xuemei Liang1, Yuhuan Zhao2, Tianjiao Xu3
1The Fourth Affiliated Hospital of Qiqihar Medical University, Qiqihar 161000, China.
Iranian journal of public health
|August 8, 2023
概括
在抑郁症模型中,Catalpol显示出抗抑郁和抗炎作用. 它可以通过调节神经炎症来帮助治疗抑郁症,可能与NF-κB抑制剂结合使用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 抑郁症是一种复杂的疾病,具有神经炎症成分.
- 慢性不可预测的轻度压力 (CUMS) 是一种常见的模式,用于诱导动物的类似抑郁的行为.
- NF-κB信号通路与神经炎症和抑郁症有关.
研究的目的:
- 为了研究catalpol.pol的抗抑郁和抗炎作用.
- 在CUMS诱导的抑郁模型中探索catalpol在调节神经炎症中的作用.
- 为了检查catalpol和NF-κB抑制剂在抑郁症治疗中的联合作用.
主要方法:
- 在老鼠身上进行了CUMS,以建立一种抑郁模型.
- 用行为测试 (体重,糖分消耗,休息时间) 来评估抑郁症.
- 研究人员使用ELISA和西式斑点测试来测量炎症标记物 (iNOS,ROS,caspase-1,IL-1β,IL-18) 和信号蛋白 (TLR4,MAPK,NF-κB).
- 还使用了LPS诱导的细胞模型.
主要成果:
- 在老鼠中,CUMS诱导了类似于抑郁的行为.
- 卡塔尔波尔治疗逆转了CUMS诱导的变化,并减少了炎症标记物和NF-κB信号通路蛋白的表达.
- 在LPS诱导的细胞模型中,catalpol还降低了炎症标记物和NF-κB通路蛋白.
结论:
- 在抑郁症模型中,Catalpol表现出显著的抗抑郁和抗炎性质.
- 卡塔尔波尔可以通过通过NF-κB通路调节神经炎症来发挥其治疗作用.
- 将catalpol与NF-κB抑制剂结合在一起,为抑郁症提供了潜在的治疗策略.
相关概念视频
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
G-protein Coupled Receptors
120.3K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
120.3K
MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K


